Antibiotic resistance and its cost: is it possible to reverse resistance?
Top Cited Papers
- 8 March 2010
- journal article
- review article
- Published by Springer Nature in Nature Reviews Microbiology
- Vol. 8 (4) , 260-271
- https://doi.org/10.1038/nrmicro2319
Abstract
Most antibiotic resistance mechanisms are associated with a fitness cost that is typically observed as a reduced bacterial growth rate. The magnitude of this cost is the main biological parameter that influences the rate of development of resistance, the stability of the resistance and the rate at which the resistance might decrease if antibiotic use were reduced. These findings suggest that the fitness costs of resistance will allow susceptible bacteria to outcompete resistant bacteria if the selective pressure from antibiotics is reduced. Unfortunately, the available data suggest that the rate of reversibility will be slow at the community level. Here, we review the factors that influence the fitness costs of antibiotic resistance, the ways by which bacteria can reduce these costs and the possibility of exploiting them.Keywords
This publication has 150 references indexed in Scilit:
- The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosisProceedings of the National Academy of Sciences, 2009
- Genetic Determinants of Resistance to Fusidic Acid among Clinical Bacteremia Isolates of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2009
- Association between Antimicrobial Consumption and Resistance in Escherichia coliAntimicrobial Agents and Chemotherapy, 2009
- Accumulation of mutants in “aging” bacterial colonies is due to growth under selection, not stress-induced mutagenesisProceedings of the National Academy of Sciences, 2008
- Genetic and Phenotypic Identification of Fusidic Acid-Resistant Mutants with the Small-Colony-Variant Phenotype in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2007
- Multiple mechanisms to ameliorate the fitness burden of mupirocin resistance in Salmonella typhimuriumMolecular Microbiology, 2007
- Fitness Costs of Fluoroquinolone Resistance in Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2007
- Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genesProceedings of the National Academy of Sciences, 2006
- Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infectionsNature Reviews Microbiology, 2006
- Effect of antimicrobial agents on the ecological balance of human microfloraThe Lancet Infectious Diseases, 2001